3 %VIA positivity was 3% among the general population.
Nigeriacancer du col de l'utérusobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
8 823 evidences · page 167 / 353
3 %VIA positivity was 3% among the general population.
Nigeriacancer du col de l'utérusobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations
33,3 %Among 339 adult patients managed for chronic conditions in Yenagoa, Bayelsa State, Nigeria, 113 (33.3%) forfeited necessities as a coping strategy for healthcare costs.
Nigeriachronic diseasespublié 2025West African journal of medicinePubMeddocument de 8 observations
14 daysViral clearance of MPXV appeared to be relatively rapid, with most samples being MPXV-negative within 14 days.
NigeriampoxHAL · Unilimdocument de 102 observations
81,5 %The pooled specificity of malaria rapid diagnostic tests (RDTs) in Nigeria was 81.5%.
Nigeriapaludismepublié 2025Malaria journalPubMeddocument de 2 observations
0,61 inoculations/person/nightEntomological inoculation rate of Anopheles mosquitoes was 0.61 in Kargo.
Nigeriapaludismepublié 2023Parasitology researchPubMeddocument de 8 observations
88,89 %88.89% of sickle cell anaemia patients screened using Natriuretic peptide were at risk of developing pulmonary hypertension (NT-proBNP levels ≥ 160 pg/ml).
Nigeriadrépanocytosepublié 2022West African journal of medicinePubMeddocument de 8 observations
14,5 %Twenty-five (14.5%) patients had severe disease.
NigeriaCOVID-19observé 2020publié 2020West African journal of medicinePubMeddocument de 8 observations
25,6 %The second most common indication for treatment was diabetic macular edema (DME) in 10 eyes (25.6%).
Nigeriadiabetic macular edemapublié 2025Journal francais d'ophtalmologiePubMeddocument de 8 observations
4 %Among enrolled participants, 1 (4%) had a PHQ-9 score ≥17.
Nigeriadépressionpublié 2025JMIR research protocolsPubMeddocument de 4 observations
25,6 %Only 25.6% of study participants knew about the positive role of community engagement and education in reducing the prevalence of sickle cell disease and alleviating sickle cell disease crises.
Nigeriadrépanocytosepublié 2023Frontiers in geneticseurope_pmcdocument de 5 observationsDOI 10.3389/fgene.2023.1052444
Les projets de démonstration de l’efficacité et de la performance de l’IVA pour le dépistage du cancer du col utérin montrent des résultats concluants à Madagascar, au Malawi, au Nigéria, en Ouganda, en Tanzanie et en Zambie en 2009.
Madagascar · Malawi · Nigeria · Ouganda · Tanzaniecancer du col de l'utérusobservé 2009HAL · Unilimdocument de 81 observations
1,2 %The prevalence of HIV/TB coinfection in Cross River State, Nigeria was 1.2%.
NigeriaHIV/TB coinfectionpublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 19 observations
25,3 %Among 641 participants in Lagos state, Nigeria, 162 (25.3%) were living with HIV.
NigeriaVIH/sidaobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations
100 %The sensitivity and specificity for SS, SC, AS, AC, and AA genotypes by HemotypeSC relative to PCR were each 100%.
Nigeriadrépanocytosepublié 2021Global pediatric healtheurope_pmcdocument de 5 observations
17 %The prevalence of placental parasitaemia in the NC group was 17%.
Nigeriapaludismepublié 2007Malaria journaleurope_pmcdocument de 6 observationsDOI 10.1186/1475-2875-6-88
1 600 000 deathsOver 1.6 million Nigerians have succumbed to AIDS since its discovery.
NigeriaVIH/sidapublié 2024Annals of African medicinePubMeddocument de 12 observations
68 patientsSixty-eight children aged 5–17 years (mean age 10.6 ± 0.4 years; 56% male) were randomized in a double-blind RCT of oral L-arginine-hydrochloride for sickle cell anemia vaso-occlusive painful crisis in Nigeria.
Nigeriasickle cell anemia vaso-occlusive painful crisispublié 2021American journal of hematologyPubMeddocument de 5 observations
49,9 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, surgery was performed on 49.9% (303/607) of patients.
Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations
28,8 %The I431V mutation was found in 19 of 66 pretreatment pfdhps sequences, representing 28.8%.
Nigeriapaludismepublié 2021Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 5 observations
15,4 %HIV prevalence was 15.4%–23.9% at highway settlements in Nigeria.
NigeriaVIH/sidaobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations
Patients with HIV on HAART have thicker optic nerves compared with the general population in Kano, Nigeria.
NigeriaVIH/sidaobservé October 2017 to June 2018publié 2019Nigerian journal of clinical practicePubMeddocument de 5 observations
75 %The cure rate for pyrimethamine-sulfadoxine was 75.0% on day 28.
Nigeriapaludismeobservé day 28publié 2004Clinical drug investigationeurope_pmcdocument de 13 observations
4,1 μg/mLFraction IMD of I. senegalensis leaves extract exhibited an IC50 of 4.1 ± 0.1 μg/mL against Plasmodium falciparum 7G8 strain (chloroquine-resistant).
NigeriapaludismeHAL · Unilimdocument de 39 observations
96 %The triple mutant haplotype (S108N+N51I+C59N) was present in 96.0% of Plasmodium falciparum isolates from children with haemoglobin AA.
Nigeriapaludismepublié 2021West African journal of medicinePubMeddocument de 3 observations
All tick samples were negative for African swine fever virus (ASFV) DNA.
NigeriaAfrican swine fever virus (ASFV)publié 2025Pathogens (Basel, Switzerland)europe_pmcdocument de 5 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.